Holen Sie sich die Stockscreener-App
2.75
4.18%
-0.12
Handel nachbörslich:
2.69
-0.06
-2.18%
Schlusskurs vom Vortag:
$2.87
Offen:
$2.9
24-Stunden-Volumen:
116.24K
Relative Volume:
1.48
Marktkapitalisierung:
$142.55M
Einnahmen:
$63.69M
Nettoeinkommen (Verlust:
$-44.82M
KGV:
-1.375
EPS:
-2
Netto-Cashflow:
$-30.56M
1W Leistung:
+0.00%
1M Leistung:
+26.15%
6M Leistung:
+49.46%
1J Leistung:
-1.79%
1-Tages-Spanne:
$2.75
$2.90
1-Wochen-Bereich:
$2.60
$2.94
52-Wochen-Spanne:
$1.35
$3.50
Mdxhealth Sa Stock (MDXH) Company Profile
Firmenname
Mdxhealth Sa
Sektor
Branche
Telefon
-
Adresse
-
Vergleichen Sie MDXH mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
MDXH
Mdxhealth Sa
|
2.75 | 142.55M | 63.69M | -44.82M | -30.56M | -2.00 |
|
TMO
Thermo Fisher Scientific Inc
|
484.79 | 180.28B | 43.21B | 6.58B | 6.17B | 17.29 |
|
DHR
Danaher Corp
|
209.14 | 147.31B | 24.01B | 3.41B | 4.86B | 4.70 |
|
IDXX
Idexx Laboratories Inc
|
663.92 | 52.18B | 4.04B | 985.66M | 774.34M | 12.01 |
|
A
Agilent Technologies Inc
|
120.29 | 33.33B | 6.63B | 1.17B | 1.19B | 4.05 |
|
IQV
Iqvia Holdings Inc
|
190.23 | 31.60B | 15.50B | 1.33B | 2.16B | 7.34 |
Mdxhealth Sa Stock (MDXH) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-07-17 | Eingeleitet | Craig Hallum | Buy |
| 2024-10-31 | Eingeleitet | Lake Street | Buy |
| 2023-05-31 | Eingeleitet | TD Cowen | Outperform |
| 2022-07-18 | Fortgesetzt | Oppenheimer | Outperform |
Mdxhealth Sa Aktie (MDXH) Neueste Nachrichten
Using RSI to spot recovery in MDxHealth SABond Market & Weekly Return Optimization Alerts - Newser
MDxHealth (MDXH) Expected to Announce Quarterly Earnings on Wednesday - Defense World
What MACD and RSI say about MDxHealth SAJuly 2025 Drop Watch & Capital Efficient Trade Techniques - Newser
Automated trading signals detected on MDxHealth SAFree Daily Volume Spike Trading Signals - Newser
MDxHealth SA stock trend forecastDividend Hike & Weekly Consistent Profit Watchlists - Newser
Why MDxHealth SA stock attracts strong analyst attentionMarket Activity Recap & Weekly Sector Rotation Insights - Newser
What makes MDxHealth SA stock price move sharplyMulti-Timeframe Confluence Picks - thegnnews.com
Will MDxHealth SA stock recover after recent dropPredictable Entry Strategy With Technical Backing - Newser
News impact scoring models applied to MDxHealth SADaily Market Movers Screener with Filters - Newser
MDxHealth SA stock prediction for this week3-Day Market Movement Forecast Analysis - Newser
Earnings visualization tools for MDxHealth SAConsistent Gain Plan with AI Support - Newser
Is MDxHealth SA forming a bottoming baseStock Performance Summary Over One Year - Newser
Financial Analysis: MDxHealth (NASDAQ:MDXH) and Standard BioTools (NASDAQ:LAB) - Defense World
Order flow analysis tools used on MDxHealth SAReal Trader Watchlist with Entry Targets - Newser
Bio-Techne takes a hit on Exodx sale to Mdxhealth - BioWorld MedTech
MDxHealth SA (MDXH) Reports Q2 Loss, Tops Revenue Estimates - MSN
MDxHealth SA (MDXH) Q2 2025 Earnings Call Highlights: Record Revenue Growth and Strategic ... - Yahoo Finance
MDxHealth ADR earnings missed by $0.03, revenue topped estimates - Investing.com South Africa
MDxHealth Announces Q2 Results and Strategic Acquisition of Exosome Diagnostics - TipRanks
Bio-Techne announces Exosome Diagnostics divestiture - MSN
Bio-techne to sell exosome diagnostics business to mdxhealth By Investing.com - Investing.com Australia
Bio-techne to sell exosome diagnostics business to mdxhealth - Investing.com
Bio-Techne Sells Prostate Cancer Test Business to Strengthen Core Operations: Strategic Shift Revealed - Stock Titan
Mdxhealth Reports Preliminary Second Quarter 2025 Results, Reaches Positive Adjusted EBITDA, and Announces Acquisition of Exosome Diagnostics Business from Bio-Techne - The Manila Times
MDxHealth Hits Profitability Milestone and Expands Diagnostic Portfolio with Strategic $15M ExoDx Acquisition - Stock Titan
MACD Cross Could Confirm Trend in MDxHealth SATarget Return Focused Trade Insights Shared - metal.it
Is MDxHealth SA a growth stock or a value stockOutstanding capital growth - Jammu Links News
When is MDxHealth SA stock expected to show significant growthUnlock expert trading strategies for growth - Jammu Links News
What are the latest earnings results for MDxHealth SACapitalize on momentum-driven investment opportunities - Jammu Links News
Is MDxHealth SA stock overvalued or undervaluedUnlock exclusive stock market insights - Jammu Links News
Why is MDxHealth SA stock attracting strong analyst attentionMaximize returns with expert trading insights - Jammu Links News
How does MDxHealth SA compare to its industry peersExceptional stock performance - Jammu Links News
How many analysts rate MDxHealth SA as a “Buy”Unlock powerful market trend analysis - Jammu Links News
What catalysts could drive MDxHealth SA stock higher in 2025Free Stock Market Trend Analysis - Jammu Links News
What drives MDxHealth SA stock priceSuperior profit margins - Jammu Links News
Is it the right time to buy MDxHealth SA stockUnlock exclusive trading strategies - Jammu Links News
What are the technical indicators suggesting about MDxHealth SACapitalize on market trends with confidence - Jammu Links News
What are analysts’ price targets for MDxHealth SA in the next 12 monthsFind the best stocks for sustainable growth - Jammu Links News
Finanzdaten der Mdxhealth Sa-Aktie (MDXH)
Umsatz
Nettogewinn
Free Cashflow
ENV
3.96%
1.32%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):